{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:38Z","timestamp":1793146718064,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2025.103280","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:58:30Z","timestamp":1764694710000},"page":"103280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study"],"prefix":"10.1016","volume":"10","author":[{"given":"Omotola O.","family":"Olasupo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Iserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Keepanasseril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quazi","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab Salim","family":"Ali Al-Housni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Germini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Eric","family":"Tarride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Blydt-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Belletrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Matino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Khalife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Brose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Malcolmson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Uminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Moorehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"St-Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vezina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serebrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Pelland-Marcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Tole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amye","family":"Harrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacGregor","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roona","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Carcao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai W.","family":"Phua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Chiu","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103280_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"The WFH guidelines for the management of hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd ed","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.103280_bib2","series-title":"FDA approves new treatment to prevent bleeding in certain patients with hemophilia A","year":"2020"},{"key":"10.1016\/j.rpth.2025.103280_bib3","series-title":"Adverse Events. StatPearls","author":"Skelly","year":"2025"},{"key":"10.1016\/j.rpth.2025.103280_bib4","series-title":"Adverse drug reactions. StatPearls","author":"Kommu","year":"2025"},{"key":"10.1016\/j.rpth.2025.103280_bib5","series-title":"PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages \u2013 a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation","article-title":"Definitions of adverse events, seriousness and causality","author":"Coomarasamy","year":"2016"},{"key":"10.1016\/j.rpth.2025.103280_bib6","series-title":"Adverse Event Detection, Processing, and Reporting. Registries for evaluating patient outcomes: a user\u2019s guide","author":"Gliklich","year":"2014"},{"key":"10.1016\/j.rpth.2025.103280_bib7","first-page":"1","article-title":"International drug monitoring: the role of national centres. Report of a WHO meeting","volume":"498","year":"1972","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.rpth.2025.103280_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician\u2019s guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2025.103280_bib9","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0049-3848(10)70150-X","article-title":"EUHASS: The European Haemophilia Safety Surveillance system","volume":"127","author":"Makris","year":"2011","journal-title":"Thrombosis Res"},{"key":"10.1016\/j.rpth.2025.103280_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102461","article-title":"Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)","volume":"8","author":"Fischer","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103280_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14740338.2019.1574743","article-title":"Safety of recombinant coagulation factors in treating hemophilia","volume":"18","author":"Morfini","year":"2019","journal-title":"Expert Opin Drug Saf, Taylor & Francis"},{"key":"10.1016\/j.rpth.2025.103280_bib15","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1111\/hae.14432","article-title":"Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors","volume":"27","author":"Hassan","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.103280_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/2042098611415566","article-title":"Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes","volume":"2","author":"hapiro","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.rpth.2025.103280_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.rpth.2025.103280_bib18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2025.103280_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2025.103280_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1160\/TH16-10-0765","article-title":"Confirmation of longer FIX activity half-life with prolonged sample collection after single doses of nonacog alfa in patients with haemophilia B","volume":"117","author":"Hua","year":"2017","journal-title":"Thromb Haemost Schattauer GmbH"},{"key":"10.1016\/j.rpth.2025.103280_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000488060","article-title":"Extended half-life factor VIII and factor IX preparations","volume":"45","author":"Graf","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.rpth.2025.103280_bib22","series-title":"Allergy. StatPearls","author":"Dougherty","year":"2025"},{"key":"10.1016\/j.rpth.2025.103280_bib23","series-title":"Epidemiology: An Introduction","author":"Rothman","year":"2025"},{"key":"10.1016\/j.rpth.2025.103280_bib24","series-title":"Hoffmann-La Roche Ltd: Indication: Bleeding prevention, hemophilia A. Canadian Agency for Drugs and Technologies in Health","year":"2021"},{"key":"10.1016\/j.rpth.2025.103280_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/17474086.2017.1272410","article-title":"The current state of adverse event reporting in hemophilia","volume":"10","author":"Van Vulpen","year":"2017","journal-title":"Expert Review of Hematology"},{"key":"10.1016\/j.rpth.2025.103280_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102228","article-title":"Inhibitors in hemophilia: association with surgery plans and outcomes in a retrospective cohort study","volume":"7","author":"Olasupo","year":"2023","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1016\/j.rpth.2025.103280_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/joim.12456","article-title":"Safety surveillance in haemophilia and allied disorders","volume":"279","author":"Lassila","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.rpth.2025.103280_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/hae.70039","article-title":"Trends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry","volume":"31","author":"Fischer","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2025.103280_bib29","article-title":"Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B","volume":"2","author":"Olasupo","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2025.103280_bib30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2023.2293096","article-title":"Efficacy\/effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysis","volume":"16","author":"Muniz","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.rpth.2025.103280_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/bmjebm-2022-112215","article-title":"Catalogue of bias: novelty bias","volume":"28","author":"Luo","year":"2023","journal-title":"BMJ Evidence-Based Medicine"},{"key":"10.1016\/j.rpth.2025.103280_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.transci.2018.07.011","article-title":"Treatment and prevention of bleeding in congenital hemophilia A patients with inhibitors","volume":"57","author":"Teitel","year":"2018","journal-title":"Transfusion and Apheresis Science"},{"key":"10.1016\/j.rpth.2025.103280_bib33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00002018-200225060-00012","article-title":"Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria","volume":"25","author":"Shakir","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.rpth.2025.103280_bib34","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.6558","article-title":"Development of a Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo): Study Protocol","volume":"5","author":"Iorio","year":"2016","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.rpth.2025.103280_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40814-018-0253-0","article-title":"The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia","volume":"4","author":"Skinner","year":"2018","journal-title":"Pilot and Feasibility Studies"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:57:06Z","timestamp":1778896626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925006041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2475037925006041"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103280","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103280"}}